Form 4: Vericel Corp Director Robert Zerbe Reports Stock Transactions

Director Robert Zerbe reports acquisition and disposal of Vericel Corp stock and derivative securities due to RSU vesting and option grants.

Summary

• Robert Zerbe, a director of Vericel Corp, filed a Form 4 detailing changes in beneficial ownership.
• On April 30, 2025, Zerbe acquired 3,200 shares of common stock through the vesting of Restricted Stock Units (RSUs) granted on May 1, 2024.
• Zerbe also acquired 8,000 stock options with an exercise price of $38.02, vesting monthly over one year from April 30, 2025, and expiring on April 30, 2035.
• Additionally, Zerbe acquired 3,200 RSUs that vest on the earlier of April 30, 2026, or the date of the first Annual Meeting of Stockholders following April 30, 2025.
• Following these transactions, Zerbe directly owns 29,795 shares of common stock, 8,000 stock options, and 3,200 RSUs.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports transactions by a company director, which is a normal part of corporate governance.

Positives

• The acquisition of stock options by a director could be seen as a positive sign, indicating confidence in the company's future performance.
• The vesting of RSUs suggests that performance milestones have been met.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The transactions could influence investor sentiment, depending on how they interpret the director's actions.

Key Dates

Keywords

Form 4, beneficial ownership, Vericel Corp, VCEL, Robert Zerbe, stock options, RSU, restricted stock units, director